Search Results 231-240 of 17553 for Assay

1. A Study to Evaluate PDS0101 and Pembrolizumab Combination to Treat Subjects with HPV16 + Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   using the FDA-approved Dako PD-L1 immunohistochemistry (IHC) 22C3 PharmDx Assay. - No prior receipt of any immunological therapy for metastatic disease ...

2. Services - Bioinformatics Core - Mayo Clinic Research

   Epigenomics: Methylation sequencing (Methylseq), chromatin immunoprecipitation sequencing (ChIPseq), assay for transposase-accessible chromatin sequencing ...

3. Mayo Clinic IDs Immune System Glitch Tied to Fourfold Higher Likelihood of Death

   Free light chain levels can be measured by using a serum free light chain assay, a simple blood test. This test is often used to monitor light chain levels in ...

4. Mayo Clinic experts present key cancer research findings at ASCO

   Oral Abstract Session: Tissue-free circulating tumor DNA assay and patient outcome in a phase 3 trial of FOLFOX-based adjuvant chemotherapy (Alliance N0147)

5. Cardiovascular Medicine - Clinical trials

   Rochester, Minn. The purporse of this study is to determine if biomarker assay obtained at baseline can predict future risk of cardiovascular adverse events, ...

6. Infectious Diseases - Clinical trials

   The purpose of this study is to evaluate the new QFT-Plus assay compared to the QFT-Gold assay and the tuberculin skin test results (as available) for the ...

7. Overview - Antibody Hybridoma Core - Mayo Clinic Research

   Monoclonal antibodies can be used for research and development of clinical diagnostic assays and therapeutics. All Antibody Hybridoma Core services are ...

8. Atrial Flutter Clinical Trials - Mayo Clinic Research

   ... assay. New-onset Atrial Fibrillation and Flutter Following Cardiac Surgery Rochester, MN. The aims of this investigation are: To assess the predictive value ...

9. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

   Subjects who are HCV antibody positive will be screened for HCV RNA by any RT-PCR or bDNA assay. If HCV antibody is positive, eligibility will be determined ...

10. T Cell Response to COVID19 Vaccinated Individuals - Mayo Clinic

    This will be accomplished by utilizing the the immunoSEQ Human T-cell Receptor Beta (hsTCB) Assay (Adaptive Biothechnologies) and the publicly available ...